CLINICAL_TRIALS
trial_result
· 2017-12-04
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. [Phase 3]
Summary
This clinical trial update reports the completion of a Phase 3 study evaluating two dose strengths of dalfampridine extended-release tablets for efficacy and sa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acorda Therapeutics | Conditions: Post-Ischemic Stroke | Phase 3 | Status: COMPLETED | Results posted: 2017-12-04